Patents by Inventor James H. Brauker

James H. Brauker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250161567
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 22, 2025
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Publication number: 20250161566
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Application
    Filed: January 17, 2025
    Publication date: May 22, 2025
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Publication number: 20250152816
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Application
    Filed: January 14, 2025
    Publication date: May 15, 2025
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Patent number: 12246166
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Grant
    Filed: July 26, 2024
    Date of Patent: March 11, 2025
    Assignee: Dexcom, Inc.
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Patent number: 12226617
    Abstract: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
    Type: Grant
    Filed: December 20, 2021
    Date of Patent: February 18, 2025
    Assignee: Dexcom, Inc.
    Inventors: James H. Brauker, Mark A. Tapsak, Sean T. Saint, Apurv Ullas Kamath, Paul V. Neale, Peter C. Simpson, Michael Robert Mensinger, Dubravka Markovic
  • Publication number: 20250032714
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Application
    Filed: October 15, 2024
    Publication date: January 30, 2025
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Publication number: 20250032716
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Application
    Filed: October 15, 2024
    Publication date: January 30, 2025
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Publication number: 20250032715
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Application
    Filed: October 15, 2024
    Publication date: January 30, 2025
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Publication number: 20240399060
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Application
    Filed: August 16, 2024
    Publication date: December 5, 2024
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Publication number: 20240382679
    Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
    Type: Application
    Filed: July 26, 2024
    Publication date: November 21, 2024
    Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
  • Patent number: 12115357
    Abstract: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: October 15, 2024
    Assignee: DEXCOM, INC.
    Inventors: James H. Brauker, Mark A. Tapsak, Sean T. Saint, Apurv Ullas Kamath, Paul V. Neale, Peter C. Simpson, Michael Robert Mensinger, Dubravka Markovic
  • Publication number: 20240324877
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: March 1, 2024
    Publication date: October 3, 2024
    Inventors: Mark C. Brister, Paul V. Neale, Peter C Simpson, James H. Brauker, James Patrick Thrower, Mark Shults, Rathbun Rhodes, Paul V. Goode, JR., Arnold Holmquist
  • Publication number: 20240245332
    Abstract: A transcutaneous sensor device configured for continuously measuring analyte concentrations in a host is provided. In some embodiments, the transcutaneous sensor device 100 comprises an in vivo portion 160 configured for insertion under the skin 180 of the host and an ex vivo portion 170 configured to remain above the surface of the skin 180 of the host after sensor insertion of the in vivo portion. The in vivo portion may comprise a tissue piercing element 110 configured for piercing the skin 180 of the host and a sensor body 120 comprising a material or support member 130 that provides sufficient column strength to allow the sensor body to be pushable in a host tissue without substantial buckling. The ex vivo portion 170 may be configured to comprise (or operably connect to) a sensor electronics unit and may comprise a mounting unit 150. Also described here are various configurations of the sensor body and the tissue piercing element that may be used to protect the membrane of the sensor body.
    Type: Application
    Filed: February 23, 2024
    Publication date: July 25, 2024
    Inventors: Peter C. Simpson, Robert J. Boock, Sebastian Bohm, James H. Brauker, Paul V. Neale
  • Publication number: 20240225487
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: September 26, 2023
    Publication date: July 11, 2024
    Inventors: Mark C. Brister, Steve Masterson, J. Michael Dobbles, Michael Robert Mensinger, Sean T Saint, Apurv U Kamath, James H Brauker, James Patrick Thrower
  • Publication number: 20240180462
    Abstract: Biointerface membranes are provided which can be utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device incorporating such membranes are provided.
    Type: Application
    Filed: January 5, 2024
    Publication date: June 6, 2024
    Inventors: James H Brauker, Robert J. Boock, Monica Rixman Swinney, Peter C. Simpson, Mark C. Brister, Mark Shults
  • Publication number: 20240138717
    Abstract: Disclosed herein is an analyte sensing biointerface that comprises a sensing electrode incorporated within a non-conductive matrix comprising a plurality of passageways extending through the matrix to the sensing electrode. Also disclosed herein are methods of manufacturing a sensing biointerface and methods of detecting an analyte within tissue of a host using an analyte sensing biointerface.
    Type: Application
    Filed: October 2, 2023
    Publication date: May 2, 2024
    Applicant: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker
  • Publication number: 20240130641
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: September 25, 2023
    Publication date: April 25, 2024
    Inventors: Mark C. Brister, Steve Masterson, J. Michael Dobbles, Michael Robert Mensinger, Sean T Saint, Apurv U Kamath, James H Brauker, James Patrick Thrower
  • Publication number: 20240130644
    Abstract: The present invention relates generally to variable stiffness transcutaneous medical devices including a distal portion designed to be more flexible than a proximal portion. The variable stiffness can be provided by a variable pitch in one or more wires of the device, a variable cross-section in one or more wires of the device, and/or a variable hardening and/or softening in one or more wires of the device.
    Type: Application
    Filed: January 2, 2024
    Publication date: April 25, 2024
    Inventors: Mark C. Brister, James H. Brauker
  • Publication number: 20240108258
    Abstract: The present invention relates generally to biointerface membranes utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, the invention relates to novel biointerface membranes, to devices and implantable devices including these membranes, methods for forming the biointerface membranes on or around the implantable devices, and to methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device.
    Type: Application
    Filed: October 11, 2023
    Publication date: April 4, 2024
    Inventors: James H. Brauker, Peter C. Simpson, Robert J. Boock, Monica Rixman Swinney, Mark C. Brister
  • Patent number: 11937927
    Abstract: A transcutaneous sensor device configured for continuously measuring analyte concentrations in a host is provided. In some embodiments, the transcutaneous sensor device 100 comprises an in vivo portion 160 configured for insertion under the skin 180 of the host and an ex vivo portion 170 configured to remain above the surface of the skin 180 of the host after sensor insertion of the in vivo portion. The in vivo portion may comprise a tissue piercing element 110 configured for piercing the skin 180 of the host and a sensor body 120 comprising a material or support member 130 that provides sufficient column strength to allow the sensor body to be pushable in a host tissue without substantial buckling. The ex vivo portion 170 may be configured to comprise (or operably connect to) a sensor electronics unit and may comprise a mounting unit 150. Also described here are various configurations of the sensor body and the tissue piercing element that may be used to protect the membrane of the sensor body.
    Type: Grant
    Filed: April 23, 2020
    Date of Patent: March 26, 2024
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, Robert J. Boock, Sebastian Bohm, James H. Brauker, Paul V. Neale